CytomX(CTMX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CTMX CytomX

交易中 08-27 14:47:58 EDT

1.18

-0.01

-0.87%

最高1.19	最低1.16	成交量12.85万
今开1.19	昨收1.19	日振幅2.52%
总市值9,216万	流通市值6,907万	总股本7,812万
成交额15.07万	换手率0.22%	流通股本5,855万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CTMX","market":"US","secType":"STK","nameCN":"CytomX","latestPrice":1.1797,"timestamp":1724784182398,"preClose":1.19,"halted":0,"volume":128453,"delay":0,"floatShares":58551985,"shares":78117601,"eps":0.134638,"marketStatus":"交易中","marketStatusCode":2,"change":-0.0103,"latestTime":"08-27 14:47:58 EDT","open":1.19,"high":1.19,"low":1.16,"amount":150659.24814850002,"amplitude":0.02521,"askPrice":1.18,"askSize":1746,"bidPrice":1.17,"bidSize":866,"shortable":3,"etf":0,"ttmEps":0.134638,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1724788800000},"adr":0,"listingDate":1444276800000,"adjPreClose":1.19,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":1.18,"preClose":1.19,"latestTime":"09:10 EDT","volume":17979,"amount":21459.279531300002,"timestamp":1724764219819},"postHourTrading":{"tag":"盘后","latestPrice":1.19,"preClose":1.19,"latestTime":"16:05 EDT","volume":1,"amount":1.17,"timestamp":1724702734018},"volumeRatio":0.293828,"impliedVol":0.0229,"impliedVolPercentile":0.0198},"requestUrl":"/m/hq/s/CTMX/tweets","defaultTab":"tweets","newsList":[{"id":"2460735033","title":"Cytomx Therapeutics, Inc.2024财年第二财季实现净利润-6.53百万美元，同比减少499.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460735033","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460735033?lang=zh_cn&edition=full","pubTime":"2024-08-18 00:03","pubTimestamp":1723910629,"startTime":"0","endTime":"0","summary":"8月18日，Cytomx Therapeutics, Inc.公布财报，公告显示公司2024财年第二财季净利润为-6.53百万美元，同比减少499.08%；其中营业收入为25.12百万美元，同比增加1.62%，每股基本收益为-0.08美元。从资产负债表来看，Cytomx Therapeutics, Inc.总负债1.90亿美元，其中短期债务4.86百万美元，资产负债比为0.84，流动比率为1.00。机构评级：截至2024年8月18日，当前有5家机构对Cytomx Therapeutics, Inc.目标价做出预测，其中目标均价为5.31美元，其中最低目标价为3.50美元，最高目标价为8.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081800055795a1673b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081800055795a1673b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CTMX"],"gpt_icon":0},{"id":"2459142471","title":"Cytomx Therapeutics, Inc.盘中异动 早盘大幅上涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459142471","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459142471?lang=zh_cn&edition=full","pubTime":"2024-08-15 23:09","pubTimestamp":1723734567,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日23时09分，Cytomx Therapeutics, Inc.股票出现波动，股价大幅上涨5.17%。Cytomx Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.93%。其相关个股中，Cingulate Inc.、Tempest Therapeutics, Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Cingulate Inc.、Scisparc Ltd.、Altamira Therapeutics Ltd.较为活跃，换手率分别为6412.65%、2054.17%、572.36%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Tempest Therapeutics, Inc.、Cingulate Inc.，振幅分别为103.98%、79.83%、70.46%。Cytomx Therapeutics, Inc.公司简介：CytomX Therapeutics Inc 是一家在美国运营的专注于肿瘤学的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815230927ab5ddbe4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815230927ab5ddbe4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTMX","BK4139","LENZ"],"gpt_icon":0},{"id":"2458592050","title":"Cytomx Therapeutics, Inc.盘中异动 早盘股价大涨6.78%报1.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458592050","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458592050?lang=zh_cn&edition=full","pubTime":"2024-08-09 22:45","pubTimestamp":1723214708,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日22时45分，Cytomx Therapeutics, Inc.股票出现异动，股价快速上涨6.78%。Cytomx Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.97%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Adma Biologics Inc涨幅较大，Salarius Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc.、Aditxt, Inc.较为活跃，换手率分别为68.48%、51.48%、30.37%，振幅较大的相关个股有Cingulate Inc.、An2 Therapeutics, Inc.、Brainstorm Cell Therapeutics Inc.，振幅分别为35.31%、22.48%、22.42%。Cytomx Therapeutics, Inc.公司简介：CytomX Therapeutics Inc 是一家在美国运营的专注于肿瘤学的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809224508aefe27cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809224508aefe27cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CTMX","BK4139"],"gpt_icon":0},{"id":"2457827206","title":"Cytomx Therapeutics, Inc.盘中异动 下午盘股价大跌5.16%报1.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457827206","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457827206?lang=zh_cn&edition=full","pubTime":"2024-08-08 01:23","pubTimestamp":1723051395,"startTime":"0","endTime":"0","summary":"北京时间2024年08月08日01时23分，Cytomx Therapeutics, Inc.股票出现波动，股价快速下挫5.16%。Cytomx Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.38%。其相关个股中，G1 Therapeutics, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Aditxt, Inc.涨幅较大，Aditxt, Inc.、Salarius Pharmaceuticals, Inc.、Scorpius Holdings, Inc.较为活跃，换手率分别为5019.63%、1783.65%、326.10%，振幅较大的相关个股有Aditxt, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Salarius Pharmaceuticals, Inc.，振幅分别为101.30%、69.66%、55.91%。Cytomx Therapeutics, Inc.公司简介：CytomX Therapeutics Inc 是一家在美国运营的专注于肿瘤学的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080801231596824d59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080801231596824d59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CTMX","BK4139"],"gpt_icon":0},{"id":"2457778822","title":"Cytomx Therapeutics, Inc.盘中异动 大幅下跌5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457778822","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457778822?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:31","pubTimestamp":1722864708,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时31分，Cytomx Therapeutics, Inc.股票出现波动，股价快速下挫5.34%。Cytomx Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.73%。其相关个股中，Zevra Therapeutics, Inc.、Cns Pharmaceuticals, Inc.、Okyo Pharma Ltd Com Npv 涨幅较大，Cns Pharmaceuticals, Inc.、Dermata Therapeutics, Inc.、Senti Biosciences, Inc.较为活跃，换手率分别为978.20%、33.14%、13.54%，振幅较大的相关个股有60 Degrees Pharmaceuticals, Inc.、Cue Biopharma, Inc.、Compass Therapeutics, Inc.，振幅分别为18.32%、12.33%、12.19%。Cytomx Therapeutics, Inc.公司简介：CytomX Therapeutics Inc 是一家在美国运营的专注于肿瘤学的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213148941fe2f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213148941fe2f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CTMX"],"gpt_icon":0},{"id":"2456400222","title":"CytomX Therapeutics Inc    预计每股亏损 14 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2456400222","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456400222?lang=zh_cn&edition=full","pubTime":"2024-08-02 20:26","pubTimestamp":1722601590,"startTime":"0","endTime":"0","summary":"   * CytomX Therapeutics Inc    将于8月8日公布截至2024年6月30日的财报，预计该公司的季度收入将出现下降。* 根据LSEG的数据，7位分析师的平均预期显示，这家总部位于加利福尼亚州旧金山南部的公司的营收预计将从去年同期的2472万美元下降19.1%，至19995万美元。* LSEG分析师对CytomX Therapeutics Inc的平均预期是每股亏损14美分。* 华尔街对 CytomX Therapeutics Inc 的 12 个月目标价中位数为 3.59 美元，高于其上次收盘价 1.34 美元。8月2日 - 以前季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTMX","LENZ"],"gpt_icon":0},{"id":"2455662441","title":"Cytomx Therapeutics, Inc.盘中异动 股价大跌5.29%报1.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455662441","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455662441?lang=zh_cn&edition=full","pubTime":"2024-07-29 23:23","pubTimestamp":1722266613,"startTime":"0","endTime":"0","summary":"北京时间2024年07月29日23时23分，Cytomx Therapeutics, Inc.股票出现波动，股价急速下跌5.29%。Cytomx Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Lipella Pharmaceuticals Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Nls Pharmaceutics Ltd.涨幅较大，Lipella Pharmaceuticals Inc.、Salarius Pharmaceuticals, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为2118.98%、695.39%、214.88%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Nls Pharmaceutics Ltd.、Anew Medical Inc C/Wts 21/06/2029 ，振幅分别为151.15%、75.11%、57.78%。Cytomx Therapeutics, Inc.公司简介：CytomX Therapeutics Inc 是一家在美国运营的专注于肿瘤学的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240729232333af94a4eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240729232333af94a4eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CTMX"],"gpt_icon":0},{"id":"2453712373","title":"Cytomx Therapeutics, Inc.盘中异动 下午盘快速拉升5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453712373","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453712373?lang=zh_cn&edition=full","pubTime":"2024-07-23 03:21","pubTimestamp":1721676095,"startTime":"0","endTime":"0","summary":"北京时间2024年07月23日03时21分，Cytomx Therapeutics, Inc.股票出现波动，股价大幅拉升5.07%。Cytomx Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.92%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大，Hepion Pharmaceuticals, Inc.、Scisparc Ltd.、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为123.74%、116.51%、85.54%，振幅较大的相关个股有Anew Medical Inc C/Wts 21/06/2029 、Mei Pharma, Inc.、木薯科学，振幅分别为44.07%、37.06%、33.41%。Cytomx Therapeutics, Inc.公司简介：CytomX Therapeutics Inc 是一家在美国运营的专注于肿瘤学的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723032135af9376c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723032135af9376c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CTMX"],"gpt_icon":0},{"id":"2434401563","title":"HC Wainwright &amp; Co.：重申CytomX Therapeutics(CTMX.US)中性评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2434401563","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2434401563?lang=zh_cn&edition=full","pubTime":"2024-05-09 22:08","pubTimestamp":1715263705,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["CTMX","BK4139","LENZ"],"gpt_icon":0},{"id":"2434906260","title":"Wedbush：上调CytomX Therapeutics(CTMX.US)评级，由中性调整至优于大市评级, 目标价由3.00美元调整至8.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2434906260","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2434906260?lang=zh_cn&edition=full","pubTime":"2024-05-09 21:15","pubTimestamp":1715260541,"startTime":"0","endTime":"0","summary":"Wedbush：上调CytomX Therapeutics(CTMX.US)评级，由中性调整至优于大市评级, 目标价由3.00美元调整至8.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405092115438aed03f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405092115438aed03f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTMX","LENZ"],"gpt_icon":0},{"id":"2434093784","title":"BUZZ-CytomX Therapeutics 因癌症疗法试验数据遭质疑而下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2434093784","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2434093784?lang=zh_cn&edition=full","pubTime":"2024-05-09 19:21","pubTimestamp":1715253672,"startTime":"0","endTime":"0","summary":"    5月9日 - ** CytomX Therapeutics   股价盘前暴跌28.40%至3美元 ** 该公司称  疗法 CX-904 在一项早期研究中对 6 名胰腺癌患者中的 2 人产生了部分反应** 这项研究涉及 35 名不同类型癌症的晚期转移性实体瘤患者** 威廉-布莱尔说，关于疗效的持久性以及为什么没有其他类型的肿瘤出现反应的问题，是中期更新中一直存在的问题。** 杰富瑞表示，投资者的 \"争论\"，如反应持续时间似乎很短、结直肠癌疗效不明显等，都给该公司股票带来了压力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUZZ","BK4139","LENZ","CTMX"],"gpt_icon":0},{"id":"2433420041","title":"杰富瑞投资银行：上调CytomX Therapeutics(CTMX.US)评级，由持有调整至买入评级, 目标价由2.50美元调整至8.","url":"https://stock-news.laohu8.com/highlight/detail?id=2433420041","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2433420041?lang=zh_cn&edition=full","pubTime":"2024-05-06 20:34","pubTimestamp":1714998884,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["CTMX","BK4139","LENZ"],"gpt_icon":0},{"id":"2429923385","title":"小摩：上调CytomX Therapeutics(CTMX.US)评级，由减持调整至中性评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2429923385","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2429923385?lang=zh_cn&edition=full","pubTime":"2024-04-22 20:25","pubTimestamp":1713788750,"startTime":"0","endTime":"0","summary":"小摩：上调CytomX Therapeutics(CTMX.US)评级，由减持调整至中性评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042220255987a1651f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042220255987a1651f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTMX","LENZ"],"gpt_icon":0},{"id":"2429928585","title":"小摩：上调CytomX Therapeutics(CTMX.US)评级，由减持调整至中性评级。","url":"https://stock-news.laohu8.com/highlight/detail?id=2429928585","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2429928585?lang=zh_cn&edition=full","pubTime":"2024-04-22 20:18","pubTimestamp":1713788313,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BLSP4452.SGD","IE00BKVL7J92.USD","IE00B1XK9C88.USD","LU2552382215.SGD","LU2552382058.USD","LU1244550221.USD","LENZ","LU1914381329.SGD","IE00BZ1G4Q59.USD","IE0034235188.USD","IE00BLSP4239.USD","LU0417517546.SGD","LU0208291251.USD","LU0971096721.USD","LU1363072403.SGD","LU1670628061.USD","BK4588","BK4550","LU1974910355.USD","LU0149725797.USD","LU1496350502.SGD","LU1244550577.SGD","SG9999002232.USD","BK4566","LU1496350171.SGD","LU2552382132.HKD","BK4504","LU0234572021.USD","LU0211327993.USD","LU0238689110.USD","LU0211328371.USD","LU0496365809.HKD","LU0976567544.SGD","IE00BWXC8680.SGD","IE00B3S45H60.SGD","LU2106854487.HKD","LU1668664300.SGD","LU1032466523.USD","LU0070302665.USD","LU0211326839.USD","LU0256863811.USD","BK4581","IE00B775SV38.USD","LU1162221912.USD","LU1917777945.USD","LU1244550494.USD","CTMX","BK4139","LU0211331839.USD","LU0310799852.SGD"],"gpt_icon":0},{"id":"2418536510","title":"Wedbush：重申CytomX Therapeutics(CTMX.US)评级，由中性调整至中性评级, 目标价3.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2418536510","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2418536510?lang=zh_cn&edition=full","pubTime":"2024-03-12 20:23","pubTimestamp":1710246217,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","CTMX"],"gpt_icon":0},{"id":"2418809259","title":"CytomX Therapeutics Inc    预计每股亏损 3 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2418809259","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2418809259?lang=zh_cn&edition=full","pubTime":"2024-03-09 04:17","pubTimestamp":1709929059,"startTime":"0","endTime":"0","summary":"   * CytomX Therapeutics Inc    将于3月11日公布截至2023年12月31日的季度财报，预计该公司的季度收入将有所增长。* LSEG 分析师对 CytomX Therapeutics Inc 的平均预期是每股亏损 3 美分。* 华尔街对 CytomX Therapeutics Inc 的 12 个月目标价中位数为 3.00 美元，高于其最新收盘价 2.56 美元。3月8日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTMX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cytomx.com","stockEarnings":[{"period":"1week","weight":-0.0325},{"period":"1month","weight":-0.2067},{"period":"3month","weight":-0.3352},{"period":"6month","weight":-0.5315},{"period":"1year","weight":-0.1849},{"period":"ytd","weight":-0.2323}],"compareEarnings":[{"period":"1week","weight":0.0021},{"period":"1month","weight":0.03},{"period":"3month","weight":0.0585},{"period":"6month","weight":0.1077},{"period":"1year","weight":0.2746},{"period":"ytd","weight":0.1798}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"CytomX Therapeutics, Inc.于2010年9月在特拉华州注册成立。该公司是一家临床阶段、专注于肿瘤学的生物制药公司，专注于开发旨在定位于肿瘤微环境的新型条件激活生物制剂。该公司专有、多功能、多模态的PROBODY技术平台旨在使肿瘤微环境内的生物治疗候选药物能够有条件地激活，同时最大限度地减少健康组织和循环中的药物活性。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.098508},{"month":2,"riseRate":0.444444,"avgChangeRate":-0.007093},{"month":3,"riseRate":0.222222,"avgChangeRate":-0.031361},{"month":4,"riseRate":0.444444,"avgChangeRate":-0.028412},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.068706},{"month":6,"riseRate":0.444444,"avgChangeRate":-0.024186},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.05037},{"month":8,"riseRate":0.444444,"avgChangeRate":-0.009612},{"month":9,"riseRate":0.25,"avgChangeRate":-0.027106},{"month":10,"riseRate":0.25,"avgChangeRate":-0.082803},{"month":11,"riseRate":0.777778,"avgChangeRate":0.189115},{"month":12,"riseRate":0.555556,"avgChangeRate":0.008351}],"exchange":"NASDAQ","name":"CytomX","nameEN":"CytomX Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CytomX(CTMX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CytomX(CTMX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CytomX,CTMX,CytomX股票,CytomX股票老虎,CytomX股票老虎国际,CytomX行情,CytomX股票行情,CytomX股价,CytomX股市,CytomX股票价格,CytomX股票交易,CytomX股票购买,CytomX股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CytomX(CTMX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CytomX(CTMX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}